MPLX Q2 EPS $0.83 Beats $0.81 Estimate, Sales $2.94B Beat $2.59B Estimate

MPLX (NYSE:MPLX) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.81 by 2.47 percent. This is a 25.76 percent increase over earnings of $0.66 per share from the same period

MPLX (NYSE:MPLX) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.81 by 2.47 percent. This is a 25.76 percent increase over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $2.94 billion which beat the analyst consensus estimate of $2.59 billion by 13.51 percent. This is a 22.76 percent increase over sales of $2.40 billion the same period last year.

Total
0
Shares
Related Posts
Read More

Disc Medicine Announces Planned Departure Of Chief Financial Officer Joanne Bryce; Co Initiated A Search To Fill The Position. Ms. Bryce Plans To Remain With The Co And Oversee Her Current Responsibilities Until A Successor Has Been Identified

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,

IRON